Given the opportunity, small and medium-sized enterprises (SMEs) can play a key role in developing therapies for some of society's most common diseases. It was for this reason that the European Commission (EC) supported a team of European universities and SMEs with over EUR 2 million to pursue the aims set out by the MACROCEPT project, and its daughter project KINACEPT, to find a treatment for rheumatoid arthritis.
Read more ...
HIV in arms race with human immune system, study reveals
HIV (human immunodeficiency virus) is evolving rapidly to get round the weaponry of the human immune system, according to new research by an international team of scientists. The findings highlight the difficulty of developing an effective vaccine against the fast-evolving virus.
Read more ...
Biopharmaceutical Companies Risk Delays in Producing Targeted Treatment Solutions
A new survey released by IBM (NYSE: IBM) and Silico Research reveals that if biopharmaceutical - or life-sciences - companies fail to collaborate, they risk costly delays in the production of new medicines, medical devices, diagnostics and support services.
Read more ...
Heart attacks linked with antiretroviral treatment
New research has helped to explain why patients being treated with antiretroviral drugs for HIV experience a greater incidence of heart attacks. The research was presented by doctors and researchers from the School of Medicine and Medical Sciences at University College Dublin, the Mater Misericordiae University Hospital in Dublin and the Royal College of Surgeons in Ireland at the Retroviral Conference in Montreal, Canada, on 11 February.
Read more ...
Robot Scientist offers more "intelligent" approach to drug discovery
A robot scientist that can make informed guesses about how effective different chemical compounds will be at fighting different diseases could revolutionise the pharmaceutical industry by developing more effective treatments more cheaply and quickly than current methods.
Read more ...
Gene therapy gives children a normal life
A small group of children that underwent gene therapy for a rare, inherited immune disorder are living normal lives years after the treatment, according to new research published in the New England Journal of Medicine (NEJM). The pioneering work was partly supported by the EU-funded CONSERT (Concerted safety and efficiency evaluation of retroviral transgenesis in gene therapy of inherited diseases) and CLINIGENE (European network for the advancement of clinical gene transfer and therapy) projects.
Read more ...
Study highlights tragedy of avoidable adverse drug reactions
Following the publication of a study into the frequency of Adverse Drug Reactions, First DataBank has spoken out at the tragedy of these avoidable and sometimes fatal errors. The study by PLos One entitled "Adverse Drug Reactions in Hospital In - Patients: A Prospective Analysis of 3695 Patient-Episodes" was covered this week by the BBC and highlighted that "one in seven hospital patients experience adverse drug reactions, half of which are completely avoidable".
Read more ...